Wed, Mar 13, 2019 - Page 11 News List

Taiwan Business Quick Take

Staff writer


Lotus upgrades facility

Generic drugmaker Lotus Pharmaceuticals Co (美時化學製藥) yesterday announced that it has begun upgrading its manufacturing facility in Nantou County to expand the production of oral oncology products. The upgrade is expected to be completed in five years and cost tens of millions of US dollars, the company said, adding that its board has approved capital expenditure of US$11 million for this year. The Nantou site has been audited by local, US, EU and Japanese regulatory authorities, enabling it to manufacture products for nearly every market in the world, the firm said. In addition to standard solid oral dose manufacturing, the company can produce hormonal products, soft gelatin capsules, and cytotoxic and high-potency molecules, it said.


Health2Sync launches app

Taipei-based Health2Sync (慧康生活科技) yesterday launched HealthPass, an app that grants its users full control of their health data using blockchain technology. The start-up teamed up with Bitmark Inc, a Taipei-based blockchain developer, to register users’ health data as their personal digital property. Users would be able to selectively allow certain companies and services to access their health data as part of a monetization scheme. The start-up has also tapped CTBC Bank (中信銀行) to use the lender’s blockchain-based solution to enable transactions resulting from monetization. With the help of health data analysis, insurers would be able to create tailored products based on each user’s health, the firm said.


Pharmally sales up 20.27%

Pharmally International Holding Co (康友製藥), a maker of large-volume parenteral solutions for vaccines and intravenous medicines, yesterday announced that net income last year rose 17.44 percent year-on-year to NT$1.1 billion (US$35.59 million), or earnings per share of NT$14.29, while sales rose 20.27 percent to NT$5.18 billion. Pharmally shares closed unchanged at NT$214 in Taipei trading yesterday. The shares last year saw a spike in volatility, surging to more than NT$500 on progress made at its Indonesian poultry vaccine production plant, before falling below NT$140 after a filing revealed that company officials were trimming their holdings.


Pegatron revenue slumps

Pegatron Corp (和碩) on Monday reported that revenue last month dropped 33.4 percent month-on-month, but rose 6.2 percent year-on-year to NT$81.65 billion. Revenue in the first two months rose 3.2 percent year-on-year to NT$204.28 billion, it said. The Jakarta Post reported that Pegatron’s new plant in Indonesia is expected to begin operations next month. Separately, Lite-On Technology Corp (光寶科技) on Monday reported that revenue last month declined 30.33 percent month-on-month and 16.6 percent year-on-year to NT$10.87 billion. Revenue in the first two months also fell 10.36 percent to NT$26.48 billion.


Chungwa Picture shares fall

A plan to lay off 2,500 employees sent shares in Chunghwa Picture Tubes Ltd (華映) into a tailspin yesterday, dealers said. The heavy selling emerged after the Taiwan Stock Exchange said that the financially troubled panel maker, which has filed for bankruptcy protection, would have to delist regardless of whether the restructuring plan is approved by the courts. Shares fell by the daily limit of 10 percent to close at NT$0.54.

Comments will be moderated. Keep comments relevant to the article. Remarks containing abusive and obscene language, personal attacks of any kind or promotion will be removed and the user banned. Final decision will be at the discretion of the Taipei Times.

TOP top